CD274 and neoplasm: This subtype is characterized by a higher prevalence of tumor-infiltrating lymphocytes (TILs), increased genomic instability, a higher tumor mutational burden (TMB), and elevated expression of programmed death-ligand 1 (PD-L1), all of which contribute to an active tumor immune microenvironment [13,14].